Overexpression of microRNA-1 impairs cardiac contractile function by damaging sarcomere assembly
Open Access
- 18 June 2012
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 95 (3) , 385-393
Abstract
The purpose of the present study was to evaluate the effects of overexpression of microRNA-1 (miR-1) on cardiac contractile function and the potential molecular mechanisms. Transgenic (Tg) mice (C57BL/6) for cardiac-specific overexpression of miR-1 driven by the α-myosin heavy chain promoter were generated and identified by real-time reverse-transcription polymerase chain reaction with left ventricular samples. We found an age-dependent decrease in the heart function in Tg mice by pressure–volume loop analysis. Histological analysis and electron microscopy displayed short sarcomeres with the loss of the clear zone and H-zone as well as myofibril fragmentation and deliquescence in Tg mice. Further studies demonstrated miR-1 post-transcriptionally down-regulated the expression of calmodulin (CaM) and cardiac myosin light chain kinase (cMLCK) proteins by targeting the 3′UTRs of MYLK3, CALM1, and CALM2 genes, leading to decreased phosphorylations of myosin light chain 2v (MLC2v) and cardiac myosin binding protein-C (cMyBP-C). Knockdown of miR-1 by locked nucleic acid-modified anti-miR-1 antisense (LNA-antimiR-1) mitigated the adverse changes of cardiac function associated with overexpression of miR-1. miR-1 induces adverse structural remodelling to impair cardiac contractile function. Targeting cMLCK and CaM likely underlies the detrimental effects of miR-1 on structural components of muscles related to the contractile machinery. Our study provides the first evidence that miRNAs cause adverse structural remodelling of the heart.Keywords
This publication has 43 references indexed in Scilit:
- Direct visualization of myosin-binding protein C bridging myosin and actin filaments in intact muscleProceedings of the National Academy of Sciences, 2011
- Circulating microRNAs are new and sensitive biomarkers of myocardial infarctionEuropean Heart Journal, 2010
- A translational study of circulating cell-free microRNA-1 in acute myocardial infarctionClinical Science, 2010
- Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humansEuropean Heart Journal, 2010
- Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarctionBiochemical and Biophysical Research Communications, 2010
- Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA‐1British Journal of Pharmacology, 2009
- Ablation of Ventricular Myosin Regulatory Light Chain Phosphorylation in Mice Causes Cardiac Dysfunction in Situ and Affects Neighboring Myofilament Protein PhosphorylationJournal of Biological Chemistry, 2009
- Endogenous microRNAs induced by heat‐shock reduce myocardial infarction following ischemia–reperfusion in miceFEBS Letters, 2008
- MicroRNA-133 controls cardiac hypertrophyNature Medicine, 2007
- The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2Nature Medicine, 2007